![Jack Higgins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jack Higgins
Hoofd Techniek/Wetenschap/O&O bij IMMUNOME, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Jack Higgins
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IMMUNOME, INC. | Hoofd Techniek/Wetenschap/O&O | 02-10-2023 | - |
Loopbaan van Jack Higgins
Eerdere bekende functies van Jack Higgins
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MorphImmune, Inc.
![]() MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Hoofd Techniek/Wetenschap/O&O | 01-05-2022 | 01-10-2023 |
Molecular Templates, Inc. /Old/
![]() Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Operationeel Directeur | 22-10-2013 | 01-06-2019 |
Corporate Officer/Principal | 01-06-2019 | 01-04-2021 | |
MOLECULAR TEMPLATES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 | - |
Opleiding van Jack Higgins
The University of Arkansas | Doctorate Degree |
Texas A&M University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
IMMUNOME, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Molecular Templates, Inc. /Old/
![]() Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
MorphImmune, Inc.
![]() MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Health Technology |
- Beurs
- Insiders
- Jack Higgins
- Ervaring